Compare LXRX & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXRX | ROOT |
|---|---|---|
| Founded | 1995 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 996.7M | 810.1M |
| IPO Year | 2000 | 2020 |
| Metric | LXRX | ROOT |
|---|---|---|
| Price | $1.79 | $44.27 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | $4.52 | ★ $57.00 |
| AVG Volume (30 Days) | ★ 2.0M | 175.6K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.78 | 28.96 |
| EPS | N/A | ★ 4.45 |
| Revenue | $49,803,000.00 | ★ $1,517,100,000.00 |
| Revenue This Year | N/A | $1.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.17 |
| Revenue Growth | ★ 60.24 | 28.95 |
| 52 Week Low | $1.10 | $40.91 |
| 52 Week High | $2.68 | $87.40 |
| Indicator | LXRX | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 39.11 |
| Support Level | $1.48 | $41.91 |
| Resistance Level | $1.96 | $48.06 |
| Average True Range (ATR) | 0.11 | 2.83 |
| MACD | 0.04 | -0.64 |
| Stochastic Oscillator | 70.65 | 13.44 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.